Breaking News Instant updates and real-time market news.

APTO

Aptose Biosciences

$2.74

-0.05 (-1.79%)

17:00
08/07/18
08/07
17:00
08/07/18
17:00

Aptose Biosciences reports Q EPS (30c), consensus (15c)

Total cash and cash equivalents and investments as of June 30 were $18.5M.

  • 07

    Aug

  • 04

    Sep

APTO Aptose Biosciences
$2.74

-0.05 (-1.79%)

12/13/17
HCWC
12/13/17
NO CHANGE
Target $6
HCWC
Buy
Aptose Biosciences price target raised to $6 from $4 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Aptose Biosciences to $6 saying the company's collaborators at the American Society of Hematology annual meeting presented a broad set of preclinical data, which provides a "nice boost" to the profile of CG'806. The analyst keeps a Buy rating on Aptose.
05/07/18
05/07/18
NO CHANGE

Aptose Biosciences exercises early option for CG-806 license from CrystalGenomic
Aptose Biosciences and CrystalGenomics announced that Aptose exercised its option under the 2016 Option Agreement to exclusively license CG-806, a first-in-class, non-covalent pan-inhibitor of the Bruton's tyrosine kinase, or BTK, and FMS-like tyrosine kinase 3, or FLT3, from CrystalGenomics, Inc. CG-806 is being developed as a highly potent, oral small molecule for acute myeloid leukemia, or AML, B-Cell malignancies and other hematologic malignancies. With the early exercise of the option, Aptose owns global rights to develop and commercialize CG-806 for all indications outside of Korea and China - the Licensed Territory. The exercise triggers a payment of $2M to CrystalGenomics. CrystalGenomics is eligible for regulatory and sales milestone payments, as well as royalties on product sales in the Licensed Territory.
06/15/18
HCWC
06/15/18
NO CHANGE
Target $6
HCWC
Buy
Aptose presentation at EHA strengthens profile for CG-806, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis said the presentation made today at the EHA meeting by Aptose Biosciences strengthens the profile for CG-806 and his confidence is higher that the preclinical database generated should translate to meaningful clinical responses in AML and lymphoma patients. He maintains a Buy rating and $6 price target on Aptose shares.
06/29/18
HCWC
06/29/18
NO CHANGE
Target $8.5
HCWC
Buy
Aptose Biosciences target raised to $8.50 at H.C. Wainwright after hold lifted
H.C. Wainwright analyst Joseph Pantginis raised his price target on Aptose Biosciences to $8.50 from $6.00 after the FDA lifted the clinical hold on APTO-253, stating that he believes the company has two potentially first-in and best-in class drugs for the treatment of hematological malignancies with that one and CG-806. He maintains a Buy rating on Aptose Biosciences shares, which are up 17c, or 4.5%, to $3.95 in early trading.

TODAY'S FREE FLY STORIES

ACHC

Acadia

$41.44

-0.5 (-1.19%)

13:17
11/13/18
11/13
13:17
11/13/18
13:17
Hot Stocks
Breaking Hot Stocks news story on Acadia »

Acadia trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOYA

Voya Financial

$45.98

1.395 (3.13%)

13:17
11/13/18
11/13
13:17
11/13/18
13:17
Hot Stocks
Breaking Hot Stocks news story on Voya Financial »

Voya Financial shares up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/13/18
11/13
13:17
11/13/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOYA

Voya Financial

$46.07

1.485 (3.33%)

13:16
11/13/18
11/13
13:16
11/13/18
13:16
Hot Stocks
Voya Financial capital deployment plans will emphasize share buybacks »

Voya Financial CEO Rodney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/13/18
11/13
13:16
11/13/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
11/13/18
11/13
13:15
11/13/18
13:15
Hot Stocks
Breaking Hot Stocks news story  »

USA Technologies trading…

VOYA

Voya Financial

$46.04

1.455 (3.26%)

13:15
11/13/18
11/13
13:15
11/13/18
13:15
Hot Stocks
Voya Financial lays out plans for at least 10% annual earnings growth »

Voya Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TROW

T. Rowe Price

$95.98

0.39 (0.41%)

, UPWK

Upwork

$18.19

0.59 (3.35%)

13:13
11/13/18
11/13
13:13
11/13/18
13:13
Hot Stocks
Breaking Hot Stocks news story on T. Rowe Price, Upwork »

T. Rowe Price reports…

TROW

T. Rowe Price

$95.98

0.39 (0.41%)

UPWK

Upwork

$18.19

0.59 (3.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VOYA

Voya Financial

$46.21

1.625 (3.64%)

13:11
11/13/18
11/13
13:11
11/13/18
13:11
Hot Stocks
Breaking Hot Stocks news story on Voya Financial »

Voya sees dividend…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VOYA

Voya Financial

$46.38

1.795 (4.03%)

13:10
11/13/18
11/13
13:10
11/13/18
13:10
Hot Stocks
Breaking Hot Stocks news story on Voya Financial »

Voya Financial targets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VOYA

Voya Financial

$46.38

1.795 (4.03%)

13:10
11/13/18
11/13
13:10
11/13/18
13:10
Earnings
Breaking Earnings news story on Voya Financial »

Voya Financial sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

13:08
11/13/18
11/13
13:08
11/13/18
13:08
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

CVE

Cenovus Energy

$8.51

-0.185 (-2.13%)

13:05
11/13/18
11/13
13:05
11/13/18
13:05
Options
Cenovus Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFY

Infosys

$9.39

0.06 (0.64%)

12:58
11/13/18
11/13
12:58
11/13/18
12:58
Hot Stocks
Infosys to open technology and innovation hub in Texas, hire 500 workers by 2020 »

Infosys announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

SNE

Sony

$51.64

0.09 (0.17%)

, MSFT

Microsoft

$107.45

0.56 (0.52%)

12:56
11/13/18
11/13
12:56
11/13/18
12:56
OnTheFly
Game On: Take-Two says 'Red Dead 2' has outsold first 'RDR' in just eight days »

Welcome to "Game On," The…

SNE

Sony

$51.64

0.09 (0.17%)

MSFT

Microsoft

$107.45

0.56 (0.52%)

T

AT&T

$30.63

-0.17 (-0.55%)

NTDOY

Nintendo

$0.00

(0.00%)

ATVI

Activision Blizzard

$52.93

-0.97 (-1.80%)

TTWO

Take-Two

$108.52

-0.51 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 28

    Nov

  • 03

    Mar

VOYA

Voya Financial

$46.38

1.795 (4.03%)

12:55
11/13/18
11/13
12:55
11/13/18
12:55
Hot Stocks
Breaking Hot Stocks news story on Voya Financial »

Voya Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

M

Macy's

$36.27

-0.77 (-2.08%)

, APRN

Blue Apron

$1.17

-0.08 (-6.40%)

12:47
11/13/18
11/13
12:47
11/13/18
12:47
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

M

Macy's

$36.27

-0.77 (-2.08%)

APRN

Blue Apron

$1.17

-0.08 (-6.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 28

    Nov

WIX

Wix.com

$91.01

2.54 (2.87%)

, REZI

Resideo

$21.90

0.56 (2.62%)

12:47
11/13/18
11/13
12:47
11/13/18
12:47
Earnings
Notable companies reporting after market close »

Notable companies…

WIX

Wix.com

$91.01

2.54 (2.87%)

REZI

Resideo

$21.90

0.56 (2.62%)

SWCH

Switch

$9.16

-0.18 (-1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

SIRI

Sirius XM

$6.26

0.15 (2.46%)

12:47
11/13/18
11/13
12:47
11/13/18
12:47
Conference/Events
Sirius XM management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

OESX

Orion Energy

$0.80

-0.0501 (-5.89%)

12:44
11/13/18
11/13
12:44
11/13/18
12:44
Recommendations
Orion Energy analyst commentary  »

Orion Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SBUX

Starbucks

$68.05

0.14 (0.21%)

12:41
11/13/18
11/13
12:41
11/13/18
12:41
Periodicals
Starbucks lays off 5%, or 350, corporate employees, Seattle Times reports »

As part of its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MET

MetLife

$46.01

1.29 (2.88%)

12:40
11/13/18
11/13
12:40
11/13/18
12:40
Options
8.2K Metlife Jan 47.5 - 50 call spreads bought for 82c »

8.2K Metlife Jan 47.5 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CKPT

Checkpoint Therapeutics

$2.37

0.19 (8.72%)

12:38
11/13/18
11/13
12:38
11/13/18
12:38
Hot Stocks
Checkpoint Therapeutics director Lindsay Rosenwald buys 100K shares of stock »

Checkpoint Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEAR

Turtle Beach

$15.81

0.56 (3.67%)

12:35
11/13/18
11/13
12:35
11/13/18
12:35
Options
Turtle Beach put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

KORS

Michael Kors

$49.26

1.51 (3.16%)

12:34
11/13/18
11/13
12:34
11/13/18
12:34
Hot Stocks
Michael Kors CEO sees double digit revenue growth in 2020 »

Michael Kors Chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.